These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38004428)

  • 1. Synthesis of Pyrrolo[3,4-
    Morales-Salazar I; Garduño-Albino CE; Montes-Enríquez FP; Nava-Tapia DA; Navarro-Tito N; Herrera-Zúñiga LD; González-Zamora E; Islas-Jácome A
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of bis-furyl-pyrrolo[3,4-
    Morales-Salazar I; Montes-Enríquez FP; Garduño-Albino CE; García-Sánchez MA; Ibarra IA; Rojas-Aguirre Y; García-Hernández ME; Sarmiento-Silva RE; Alcaraz-Estrada SL; Díaz-Cervantes E; González-Zamora E; Islas-Jácome A
    RSC Med Chem; 2023 Jan; 14(1):154-165. PubMed ID: 36760742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of New Polyheterocyclic Pyrrolo[3,4-
    Blanco-Carapia RE; Aguilar-Rangel EA; Rincón-Guevara MA; Islas-Jácome A; González-Zamora E
    Molecules; 2023 May; 28(10):. PubMed ID: 37241828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Polyheterocyclic Pyrrolo[3,4-b]pyridin-5-ones via a One-Pot (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization/S
    Zamudio-Medina A; García-González AN; Herrera-Carrillo GK; Zárate-Zárate D; Benavides-Macías A; Tamariz J; Ibarra IA; Islas-Jácome A; González-Zamora E
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29584639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Pyrrolo[3,4-
    Segura-Olvera D; García-González AN; Morales-Salazar I; Islas-Jácome A; Rojas-Aguirre Y; Ibarra IA; Díaz-Cervantes E; Alcaraz-Estrada SL; González-Zamora E
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31336585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Tris-Heterocycles via a Cascade IMCR/Aza Diels-Alder + CuAAC Strategy.
    Rentería-Gómez MA; Islas-Jácome A; Pharande SG; Vosburg DA; Gámez-Montaño R
    Front Chem; 2019; 7():546. PubMed ID: 31448260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of New 5-Aryl-benzo[
    Vázquez-Vera Ó; Segura-Olvera D; Rincón-Guevara MA; Gutiérrez-Carrillo A; García-Sánchez MA; Ibarra IA; Lomas-Romero L; Islas-Jácome A; González-Zamora E
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2-Tetrazolylmethyl-isoindolin-1-ones via a One-Pot Ugi-Azide/(N-Acylation/
    Rentería-Gómez A; Islas-Jácome A; Cruz-Jiménez AE; Manzano-Velázquez JC; Rojas-Lima S; Jiménez-Halla JOC; Gámez-Montaño R
    ACS Omega; 2016 Nov; 1(5):943-951. PubMed ID: 31457175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.
    Doneti R; Pasha A; Botlagunta M; Heena SK; Mutyala VVVP; Pawar SC
    Med Oncol; 2022 Sep; 39(11):179. PubMed ID: 36048256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
    Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
    Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
    Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
    Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3 + 2] Cycloaddition reactions in the synthesis of triazolo[4,5-b]pyridin-5-ones and pyrrolo[3,4-b]pyridin-2-ones.
    Gao Y; Lam Y
    J Comb Chem; 2008; 10(2):327-32. PubMed ID: 18260650
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zegheb N; Boubekri C; Lanez T; Lanez E; Küçükkılınç TT; Öz E; Khennoufa A; Khamouli S; Belaidi S
    Anticancer Agents Med Chem; 2022; 22(7):1426-1437. PubMed ID: 34170810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Still Unconquered: Enantioselective Passerini and Ugi Multicomponent Reactions.
    Wang Q; Wang DX; Wang MX; Zhu J
    Acc Chem Res; 2018 May; 51(5):1290-1300. PubMed ID: 29708723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines.
    Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM
    Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.